Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

IPG Photonics (IPGP) Financials

IPG Photonics logo
$119.00 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$119.36 +0.36 (+0.30%)
As of 05/22/2026 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for IPG Photonics

Annual Income Statements for IPG Photonics

This table shows IPG Photonics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
242 261 348 404 180 160 278 110 219 -182 31
Consolidated Net Income / (Loss)
242 261 348 404 180 160 278 111 219 -182 31
Net Income / (Loss) Continuing Operations
242 261 348 404 180 160 278 111 219 -182 31
Total Pre-Tax Income
342 367 552 534 248 206 366 183 275 -162 45
Total Operating Income
342 364 551 523 234 199 368 170 232 -208 13
Total Gross Profit
492 552 797 800 606 539 696 555 542 338 381
Total Revenue
901 1,006 1,409 1,460 1,315 1,201 1,461 1,430 1,287 977 1,004
Operating Revenue
901 1,006 1,409 1,460 1,315 1,201 1,461 1,430 1,287 977 1,004
Total Cost of Revenue
409 454 612 660 708 662 764 874 746 639 622
Operating Cost of Revenue
409 454 612 660 708 662 764 874 746 639 622
Total Operating Expenses
150 188 246 277 372 340 329 386 311 546 368
Selling, General & Admin Expense
57 66 81 102 108 110 126 131 126 124 143
Marketing Expense
32 38 50 58 78 71 78 77 86 90 98
Research & Development Expense
63 79 101 123 130 127 140 116 99 110 117
Other Operating Expenses / (Income)
-2.56 4.50 14 -6.15 13 -13 -15 4.10 - 5.52 9.35
Impairment Charge
- - 0.00 0.00 37 45 0.00 80 1.24 27 0.00
Restructuring Charge
- - 0.00 0.00 7.13 0.51 0.00 9.70 -0.29 0.00 0.60
Other Special Charges / (Income)
- - - - - 0.00 0.00 -32 0.00 190 0.00
Total Other Income / (Expense), net
-0.43 2.25 0.76 11 15 7.03 -1.40 14 43 46 32
Interest & Investment Income
-0.30 1.30 0.74 9.06 14 6.27 -1.84 13 42 45 30
Other Income / (Expense), net
-0.13 0.95 0.02 1.93 0.35 0.76 0.44 1.23 1.36 0.90 2.14
Income Tax Expense
100 106 204 130 68 45 89 73 56 20 14
Basic Earnings per Share
$4.60 $4.91 $6.50 $7.55 $3.40 $3.00 $5.21 $2.17 $4.64 ($4.09) $0.73
Weighted Average Basic Shares Outstanding
52.68M 53.07M 53.50M 53.52M 53.06M 53.19M 53.41M 50.76M 47.15M 44.34M 42.34M
Diluted Earnings per Share
$4.53 $4.85 $6.36 $7.38 $3.35 $2.97 $5.16 $2.16 $4.63 ($4.09) $0.73
Weighted Average Diluted Shares Outstanding
53.43M 53.80M 54.70M 54.73M 53.84M 53.78M 53.93M 50.92M 47.32M 44.34M 42.65M
Weighted Average Basic & Diluted Shares Outstanding
52.60M 53.10M 53.50M 53.50M 53.06M 53.53M 52.94M 47.63M 46.10M 42.55M 42.19M

Quarterly Income Statements for IPG Photonics

This table shows IPG Photonics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
55 41 24 20 -234 7.82 3.76 6.61 7.46 13 1.58
Consolidated Net Income / (Loss)
55 41 24 20 -234 7.82 3.76 6.61 7.46 13 1.58
Net Income / (Loss) Continuing Operations
55 41 24 20 -234 7.82 3.76 6.61 7.46 13 1.58
Total Pre-Tax Income
68 42 34 25 -243 22 11 8.27 16 11 1.02
Total Operating Income
56 29 19 12 -253 14 1.83 0.10 7.86 3.32 -7.74
Total Gross Profit
133 114 98 96 54 90 90 94 99 99 99
Total Revenue
301 299 252 258 233 234 228 251 251 274 265
Operating Revenue
301 299 252 258 233 234 228 251 251 274 265
Total Cost of Revenue
168 185 154 161 179 144 138 157 152 175 166
Operating Cost of Revenue
168 185 154 161 179 144 138 157 152 175 166
Total Operating Expenses
77 87 78 84 307 76 88 93 91 96 107
Selling, General & Admin Expense
31 35 31 32 33 29 33 35 35 40 36
Marketing Expense
22 22 23 22 22 22 24 26 24 24 25
Research & Development Expense
25 28 29 27 27 26 28 30 30 29 33
Other Operating Expenses / (Income)
-0.45 - 1.68 3.24 1.15 6.91 2.41 3.10 1.50 2.34 -0.20
Other Special Charges / (Income)
0.00 - -6.78 -0.67 198 - 0.00 0.00 0.00 - 14
Total Other Income / (Expense), net
12 14 15 13 11 8.06 8.79 8.17 7.80 7.24 8.76
Interest & Investment Income
12 13 14 13 11 7.41 7.44 8.00 7.28 7.13 6.92
Other Income / (Expense), net
0.55 0.20 0.33 0.19 -0.27 0.65 1.34 0.17 0.52 0.11 1.83
Income Tax Expense
13 0.73 9.50 4.86 -8.92 14 6.86 1.67 8.19 -2.71 -0.57
Basic Earnings per Share
$1.16 $0.90 $0.52 $0.45 ($5.33) $0.27 $0.09 $0.16 $0.18 $0.30 $0.04
Weighted Average Basic Shares Outstanding
47.24M 47.15M 45.96M 44.92M 43.84M 44.34M 42.60M 42.48M 42.20M 42.34M 42.24M
Diluted Earnings per Share
$1.16 $0.90 $0.52 $0.45 ($5.33) $0.27 $0.09 $0.16 $0.18 $0.30 $0.04
Weighted Average Diluted Shares Outstanding
47.39M 47.32M 46.17M 45.01M 43.84M 44.34M 42.83M 42.58M 42.56M 42.65M 42.91M
Weighted Average Basic & Diluted Shares Outstanding
46.92M 46.10M 45.57M 44.23M 43.25M 42.55M 42.53M 42.22M 42.12M 42.19M 42.44M

Annual Cash Flow Statements for IPG Photonics

This table details how cash moves in and out of IPG Photonics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
60 41 231 -366 139 196 -169 -11 -184 105 -216
Net Cash From Operating Activities
263 298 405 393 324 285 390 213 296 248 75
Net Cash From Continuing Operating Activities
263 298 405 393 324 285 390 213 296 248 75
Net Income / (Loss) Continuing Operations
242 261 348 404 180 160 278 111 219 -182 31
Consolidated Net Income / (Loss)
242 261 348 404 180 160 278 111 219 -182 31
Depreciation Expense
42 51 65 80 96 95 96 91 70 61 67
Amortization Expense
- - - - - - 2.50 -4.56 -25 -18 -14
Non-Cash Adjustments To Reconcile Net Income
54 73 77 61 154 140 104 246 101 350 90
Changes in Operating Assets and Liabilities, net
-75 -88 -84 -152 -107 -110 -91 -230 -68 36 -99
Net Cash From Investing Activities
-182 -274 -171 -563 -140 -100 -416 297 -238 209 -265
Net Cash From Continuing Investing Activities
-182 -274 -171 -563 -140 -100 -416 297 -238 209 -265
Purchase of Property, Plant & Equipment
-70 -127 -127 -160 -134 -88 -123 -110 -110 -99 -79
Acquisitions
-4.96 -48 -60 -109 -15 -0.43 0.00 -2.00 0.00 -67 0.51
Purchase of Investments
-107 -300 -212 -765 -760 -1,112 -1,941 -1,117 -1,233 -713 -943
Sale of Property, Plant & Equipment
0.16 0.66 16 1.03 0.66 0.89 1.41 27 31 29 0.92
Divestitures
- - - - - 0.00 0.00 53 0.00 -25 0.00
Sale and/or Maturity of Investments
0.00 199 213 470 768 1,099 1,648 1,446 1,074 1,083 755
Other Investing Activities, net
0.09 0.47 -0.35 0.42 0.24 -0.01 -1.52 -0.04 0.56 0.43 0.04
Net Cash From Financing Activities
-1.54 27 -3.37 -167 -37 -10 -125 -515 -236 -340 -54
Net Cash From Continuing Financing Activities
-1.54 27 -3.37 -167 -37 -10 -125 -515 -236 -340 -54
Repayment of Debt
-29 -11 -27 -3.86 -3.69 -3.74 -3.81 -18 -16 0.00 0.00
Repurchase of Common Equity
0.00 -8.95 -40 -176 -41 -38 -135 -500 -223 -344 -53
Issuance of Common Equity
14 16 29 13 7.34 33 16 5.58 3.15 4.20 -1.06
Effect of Exchange Rate Changes
-20 -9.41 - -29 - 20 -18 -5.95 -5.59 -12 28
Cash Interest Paid
0.87 0.94 2.58 3.05 2.68 2.23 2.71 3.21 1.28 0.28 0.23
Cash Income Taxes Paid
91 127 156 113 117 86 63 113 63 41 57

Quarterly Cash Flow Statements for IPG Photonics

This table details how cash moves in and out of IPG Photonics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-45 -14 -18 224 163 -264 -257 -3.86 -13 58 77
Net Cash From Operating Activities
86 106 55 53 66 74 13 -2.22 35 29 -5.46
Net Cash From Continuing Operating Activities
86 106 55 53 66 74 13 -2.22 35 29 -5.46
Net Income / (Loss) Continuing Operations
55 41 24 20 -234 7.82 3.76 6.61 7.46 13 1.58
Consolidated Net Income / (Loss)
55 41 24 20 -234 7.82 3.76 6.61 7.46 13 1.58
Depreciation Expense
17 17 16 15 15 15 15 16 16 20 16
Amortization Expense
-6.72 -7.34 -7.22 -5.79 -2.67 -1.98 -3.88 -4.43 -3.40 -2.31 -1.31
Non-Cash Adjustments To Reconcile Net Income
20 30 18 25 283 24 24 25 22 19 20
Changes in Operating Assets and Liabilities, net
0.57 25 3.42 -0.77 4.55 29 -26 -46 -6.71 -21 -42
Net Cash From Investing Activities
-72 -75 24 285 163 -263 -274 13 -31 28 95
Net Cash From Continuing Investing Activities
-72 -75 24 285 163 -263 -274 13 -31 28 95
Purchase of Property, Plant & Equipment
-26 -25 -28 -24 -23 -23 -25 -15 -21 -18 -16
Purchase of Investments
-315 -334 -227 -75 -122 -290 -333 -247 -287 -77 -33
Sale of Property, Plant & Equipment
29 0.82 25 3.01 0.26 0.04 0.18 0.38 0.04 0.32 0.81
Sale and/or Maturity of Investments
240 284 253 381 332 117 83 275 276 122 144
Other Investing Activities, net
0.12 0.11 0.16 0.03 0.20 0.04 0.05 - 0.02 -0.03 0.08
Net Cash From Financing Activities
-46 -60 -91 -119 -74 -55 -5.67 -29 -16 -3.27 -12
Net Cash From Continuing Financing Activities
-46 -60 -91 -119 -74 -55 -5.67 -29 -16 -3.27 -12
Repurchase of Common Equity
-46 -64 -90 -122 -74 -57 0.11 -30 -16 -6.53 0.00
Issuance of Common Equity
0.30 3.58 -1.16 2.95 0.08 2.33 -5.78 1.52 -0.06 3.26 -12
Effect of Exchange Rate Changes
-12 15 -5.78 5.18 9.02 -20 9.62 14 -0.61 4.55 -1.10
Cash Interest Paid
0.16 0.17 0.00 0.09 0.00 0.18 0.01 0.00 0.13 0.09 0.00
Cash Income Taxes Paid
-3.18 7.92 8.01 26 4.74 1.73 11 22 11 13 7.69

Annual Balance Sheets for IPG Photonics

This table presents IPG Photonics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,453 1,790 2,367 2,574 2,730 2,936 3,171 2,743 2,699 2,289 2,424
Total Current Assets
1,103 1,301 1,754 1,805 1,897 2,148 2,348 1,986 1,915 1,431 1,423
Cash & Equivalents
583 624 910 544 680 876 709 698 515 620 404
Short-Term Investments
107 207 206 500 503 515 805 479 663 310 436
Accounts Receivable
150 156 237 256 238 264 262 211 219 171 182
Inventories, net
204 239 308 404 381 365 461 509 454 285 313
Prepaid Expenses
26 41 48 58 56 58 73 47 38 27 46
Current Deferred & Refundable Income Taxes
34 34 45 44 39 70 37 41 26 18 43
Plant, Property, & Equipment, net
289 379 460 543 601 598 635 581 602 588 638
Total Noncurrent Assets
62 110 153 226 233 190 188 176 182 270 363
Long-Term Investments
- - - - - - - - - 0.00 77
Goodwill
0.51 20 56 101 82 41 39 38 39 67 72
Intangible Assets
12 29 51 87 74 62 53 34 26 55 50
Noncurrent Deferred & Refundable Income Taxes
30 42 27 19 31 43 48 75 89 115 124
Other Noncurrent Operating Assets
20 19 19 19 45 43 49 29 28 32 41
Total Liabilities & Shareholders' Equity
1,453 1,790 2,367 2,574 2,730 2,936 3,171 2,743 2,699 2,289 2,424
Total Liabilities
193 232 345 368 328 342 423 358 284 265 296
Total Current Liabilities
142 158 199 246 192 215 313 275 215 205 234
Accounts Payable
26 28 35 36 27 26 56 46 29 35 39
Accrued Expenses
76 102 144 155 150 177 231 203 181 152 185
Current Deferred & Payable Income Tax Liabilities
38 25 16 51 11 8.28 8.64 9.62 4.89 18 9.90
Total Noncurrent Liabilities
51 74 146 122 136 127 110 83 69 60 62
Noncurrent Deferred & Payable Income Tax Liabilities
- 36 101 81 98 93 94 83 69 60 62
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,261 1,558 2,022 2,206 2,402 2,594 2,747 2,385 2,415 2,024 2,128
Total Preferred & Common Equity
1,260 1,558 2,022 2,206 2,402 2,593 2,747 2,385 2,415 2,024 2,128
Total Common Equity
1,260 1,558 2,022 2,206 2,402 2,593 2,747 2,385 2,415 2,024 2,128
Common Stock
608 651 705 745 786 854 908 951 994 1,035 1,077
Retained Earnings
833 1,094 1,444 1,849 2,029 2,188 2,467 2,577 2,795 2,614 2,645
Treasury Stock
0.00 -8.95 -49 -225 -266 -304 -439 -938 -1,162 -1,505 -1,556
Accumulated Other Comprehensive Income / (Loss)
-181 -179 -77 -163 -147 -146 -190 -205 -213 -119 -38

Quarterly Balance Sheets for IPG Photonics

This table presents IPG Photonics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
2,963 2,671 2,696 2,673 2,598 2,495 2,355 2,317 2,379 2,381 2,422
Total Current Assets
2,119 1,916 1,924 1,920 1,830 1,718 1,570 1,443 1,474 1,435 1,433
Cash & Equivalents
869 521 573 528 496 721 884 363 359 346 481
Short-Term Investments
365 548 523 605 644 343 135 564 540 524 332
Accounts Receivable
195 237 231 230 184 176 164 177 201 166 192
Inventories, net
556 506 491 480 432 401 321 288 304 324 319
Prepaid Expenses
84 56 54 45 49 47 40 35 41 46 58
Current Deferred & Refundable Income Taxes
49 47 51 33 25 30 27 17 29 28 51
Plant, Property, & Equipment, net
662 594 609 582 586 593 590 603 621 622 636
Total Noncurrent Assets
182 161 163 170 183 184 195 271 284 324 352
Long-Term Investments
- - - - - - - - - 30 71
Goodwill
38 38 38 38 38 38 38 69 72 72 71
Intangible Assets
36 32 30 28 25 23 22 54 55 52 47
Noncurrent Deferred & Refundable Income Taxes
69 59 70 80 84 89 106 109 114 120 121
Other Noncurrent Operating Assets
38 32 25 25 35 34 28 39 43 51 43
Total Liabilities & Shareholders' Equity
2,963 2,671 2,696 2,673 2,598 2,495 2,355 2,317 2,379 2,381 2,422
Total Liabilities
382 333 298 289 258 242 241 257 275 276 306
Total Current Liabilities
296 250 228 220 192 190 194 197 217 213 247
Accounts Payable
55 41 37 33 27 26 40 38 42 40 55
Accrued Expenses
200 190 184 175 163 161 151 153 171 171 185
Current Deferred & Payable Income Tax Liabilities
25 3.10 6.61 12 2.44 3.02 3.82 6.28 4.64 2.13 7.60
Total Noncurrent Liabilities
86 83 70 69 66 52 46 60 58 63 59
Noncurrent Deferred & Payable Income Tax Liabilities
86 83 70 69 66 52 46 60 58 63 59
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,581 2,339 2,399 2,384 2,341 2,253 2,115 2,060 2,105 2,105 2,116
Total Preferred & Common Equity
2,581 2,339 2,399 2,384 2,341 2,253 2,115 2,060 2,105 2,105 2,116
Total Common Equity
2,581 2,339 2,399 2,384 2,341 2,253 2,115 2,060 2,105 2,105 2,116
Common Stock
939 957 970 978 1,003 1,014 1,025 1,040 1,053 1,064 1,076
Retained Earnings
2,669 2,637 2,699 2,754 2,819 2,840 2,606 2,618 2,624 2,632 2,647
Treasury Stock
-821 -1,051 -1,051 -1,098 -1,251 -1,374 -1,448 -1,505 -1,536 -1,552 -1,556
Accumulated Other Comprehensive Income / (Loss)
-207 -204 -219 -251 -230 -227 -69 -92 -37 -39 -51

Annual Metrics And Ratios for IPG Photonics

This table displays calculated financial ratios and metrics derived from IPG Photonics' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
17.07% 11.64% 40.02% 3.62% -9.95% -8.66% 21.66% -2.14% -9.94% -24.10% 2.73%
EBITDA Growth
20.04% 8.43% 47.74% -1.64% -45.44% -11.03% 58.91% -45.04% 8.22% -158.87% 141.62%
EBIT Growth
20.16% 6.83% 50.89% -4.68% -55.43% -14.83% 84.69% -53.65% 36.66% -188.87% 107.35%
NOPAT Growth
21.20% 6.93% 33.96% 14.04% -57.14% -8.74% 80.12% -63.29% 80.40% -178.92% 106.20%
Net Income Growth
20.74% 7.72% 33.32% 16.28% -55.40% -11.05% 73.30% -60.14% 97.61% -182.93% 117.13%
EPS Growth
19.53% 7.06% 31.13% 16.04% -54.61% -11.34% 73.74% -58.14% 114.35% -188.34% 117.85%
Operating Cash Flow Growth
46.29% 12.99% 36.18% -2.98% -17.74% -11.80% 36.58% -45.43% 39.19% -16.25% -69.61%
Free Cash Flow Firm Growth
56.35% -60.97% 93.98% -9.82% -20.26% 52.55% 44.30% -42.52% 17.30% -101.26% -4,961.04%
Invested Capital Growth
5.57% 29.89% 24.38% 26.35% 4.53% -1.63% 2.08% -3.40% 1.15% -11.60% 10.78%
Revenue Q/Q Growth
1.83% 5.95% 6.09% -2.08% -1.75% 2.56% 1.94% -2.12% -2.62% -6.20% 4.16%
EBITDA Q/Q Growth
1.31% 6.60% 8.24% -7.40% -22.13% 28.16% 5.20% -41.44% 46.80% -7.17% -8.44%
EBIT Q/Q Growth
0.83% 6.81% 8.36% -8.94% -29.14% 48.32% 5.67% -50.42% 101.35% -7.34% -42.31%
NOPAT Q/Q Growth
1.96% 5.44% -5.82% 4.86% -31.44% 55.83% 6.12% -61.35% 190.75% -7.66% -16.05%
Net Income Q/Q Growth
1.79% 5.87% -6.00% 5.90% -30.68% 50.75% 5.94% -58.81% 158.86% -22.72% 21.27%
EPS Q/Q Growth
1.57% 5.90% -6.33% 6.34% -30.64% 50.76% 5.95% -57.56% 130.35% -18.21% 4.29%
Operating Cash Flow Q/Q Growth
5.13% 12.46% 1.68% 1.16% 5.51% -13.52% -0.20% -16.79% 27.83% -11.52% -37.38%
Free Cash Flow Firm Q/Q Growth
-2.11% 40.33% -9.98% -31.18% 236.99% -25.52% 17.56% -8.38% -2.63% -110.89% -10.95%
Invested Capital Q/Q Growth
1.05% -0.54% -0.82% 6.70% -6.17% 2.70% 0.87% -10.16% -1.00% -0.09% 0.67%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
54.58% 54.89% 56.56% 54.82% 46.11% 44.89% 47.67% 38.85% 42.08% 34.61% 38.00%
EBITDA Margin
42.64% 41.42% 43.70% 41.48% 25.13% 24.48% 31.98% 17.96% 21.58% -16.74% 6.78%
Operating Margin
37.95% 36.21% 39.12% 35.85% 17.78% 16.54% 25.18% 11.86% 18.02% -21.31% 1.31%
EBIT Margin
37.94% 36.30% 39.12% 35.99% 17.81% 16.61% 25.21% 11.94% 18.12% -21.22% 1.52%
Profit (Net Income) Margin
26.85% 25.91% 24.67% 27.69% 13.71% 13.35% 19.02% 7.75% 17.00% -18.58% 3.10%
Tax Burden Percent
70.85% 71.12% 62.98% 75.63% 72.58% 77.95% 75.82% 60.41% 79.63% 112.13% 68.96%
Interest Burden Percent
99.91% 100.36% 100.13% 101.72% 106.08% 103.14% 99.50% 107.39% 117.81% 78.07% 295.92%
Effective Tax Rate
29.15% 28.88% 37.02% 24.37% 27.42% 22.05% 24.18% 39.59% 20.37% 0.00% 31.04%
Return on Invested Capital (ROIC)
42.10% 38.13% 40.29% 36.62% 13.75% 12.38% 22.24% 8.22% 15.01% -12.50% 0.78%
ROIC Less NNEP Spread (ROIC-NNEP)
42.15% 37.91% 40.24% 35.82% 12.76% 11.94% 22.32% 7.59% 12.09% -9.11% -1.61%
Return on Net Nonoperating Assets (RNNOA)
-21.12% -19.63% -20.87% -17.50% -5.93% -5.96% -11.84% -3.91% -5.89% 4.32% 0.71%
Return on Equity (ROE)
20.98% 18.50% 19.42% 19.12% 7.82% 6.42% 10.40% 4.32% 9.12% -8.18% 1.50%
Cash Return on Invested Capital (CROIC)
36.68% 12.13% 18.56% 13.34% 9.32% 14.02% 20.18% 11.68% 13.86% -0.18% -9.45%
Operating Return on Assets (OROA)
25.67% 22.52% 26.51% 21.26% 8.83% 7.04% 12.06% 5.77% 8.57% -8.31% 0.65%
Return on Assets (ROA)
18.17% 16.08% 16.72% 16.36% 6.80% 5.66% 9.10% 3.75% 8.04% -7.28% 1.32%
Return on Common Equity (ROCE)
20.97% 18.49% 19.42% 19.11% 7.82% 6.42% 10.40% 4.32% 9.12% -8.18% 1.50%
Return on Equity Simple (ROE_SIMPLE)
19.22% 16.74% 17.19% 18.33% 7.51% 6.18% 10.12% 4.64% 9.06% -8.97% 0.00%
Net Operating Profit after Tax (NOPAT)
242 259 347 396 170 155 279 102 185 -146 9.04
NOPAT Margin
26.89% 25.75% 24.64% 27.12% 12.91% 12.90% 19.09% 7.16% 14.35% -14.92% 0.90%
Net Nonoperating Expense Percent (NNEP)
-0.05% 0.22% 0.05% 0.80% 0.99% 0.44% -0.08% 0.63% 2.92% -3.39% 2.39%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 4.26% 7.65% -7.20% 0.42%
Cost of Revenue to Revenue
45.42% 45.11% 43.44% 45.18% 53.89% 55.11% 52.33% 61.15% 57.92% 65.39% 62.00%
SG&A Expenses to Revenue
6.35% 6.61% 5.73% 7.02% 8.18% 9.16% 8.62% 9.18% 9.77% 12.72% 14.26%
R&D to Revenue
7.03% 7.81% 7.16% 8.41% 9.89% 10.57% 9.55% 8.12% 7.67% 11.24% 11.70%
Operating Expenses to Revenue
16.62% 18.68% 17.45% 18.96% 28.33% 28.34% 22.49% 27.00% 24.16% 55.92% 36.70%
Earnings before Interest and Taxes (EBIT)
342 365 551 525 234 199 368 171 233 -207 15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
384 417 616 606 330 294 467 257 278 -164 68
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.74 3.37 5.68 2.74 3.20 4.60 3.34 1.93 2.11 1.55 1.42
Price to Tangible Book Value (P/TBV)
3.77 3.47 5.99 3.00 3.43 4.79 3.46 1.99 2.17 1.65 1.50
Price to Revenue (P/Rev)
5.22 5.21 8.15 4.14 5.85 9.93 6.28 3.23 3.96 3.22 3.00
Price to Earnings (P/E)
19.43 20.10 33.03 14.97 42.67 74.75 32.96 41.96 23.27 0.00 96.99
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.15% 4.97% 3.03% 6.68% 2.34% 1.34% 3.03% 2.38% 4.30% 0.00% 1.03%
Enterprise Value to Invested Capital (EV/IC)
6.83 5.80 10.90 4.19 5.19 8.52 6.08 2.82 3.16 2.02 1.73
Enterprise Value to Revenue (EV/Rev)
4.48 4.43 7.39 3.46 4.98 8.81 5.27 2.41 3.04 2.27 2.09
Enterprise Value to EBITDA (EV/EBITDA)
10.51 10.68 16.91 8.34 19.83 35.98 16.48 13.44 14.09 0.00 30.85
Enterprise Value to EBIT (EV/EBIT)
11.81 12.19 18.89 9.61 27.98 53.04 20.90 20.21 16.78 0.00 137.82
Enterprise Value to NOPAT (EV/NOPAT)
16.66 17.18 30.00 12.76 38.61 68.30 27.59 33.70 21.20 0.00 232.43
Enterprise Value to Operating Cash Flow (EV/OCF)
15.32 14.96 25.69 12.84 20.25 37.07 19.75 16.23 13.23 8.93 27.88
Enterprise Value to Free Cash Flow (EV/FCFF)
19.12 54.02 65.14 35.03 56.98 60.31 30.41 23.72 22.95 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.02 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.00 0.00 0.00
Long-Term Debt to Equity
0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.00 0.00 0.00 0.00
Financial Leverage
-0.50 -0.52 -0.52 -0.49 -0.46 -0.50 -0.53 -0.51 -0.49 -0.47 -0.44
Leverage Ratio
1.15 1.15 1.16 1.17 1.15 1.13 1.14 1.15 1.13 1.12 1.14
Compound Leverage Factor
1.15 1.15 1.16 1.19 1.22 1.17 1.14 1.24 1.34 0.88 3.36
Debt to Total Capital
1.54% 2.55% 2.36% 2.02% 1.71% 1.44% 1.23% 0.67% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.16% 0.20% 0.17% 0.16% 0.15% 0.14% 0.65% 0.67% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
1.38% 2.35% 2.19% 1.85% 1.55% 1.30% 0.58% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.09% 0.01% 0.00% 0.03% 0.03% 0.05% 0.02% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
98.38% 97.44% 97.64% 97.95% 98.26% 98.51% 98.75% 99.33% 100.00% 100.00% 100.00%
Debt to EBITDA
0.05 0.10 0.08 0.07 0.13 0.13 0.07 0.06 0.00 0.00 0.00
Net Debt to EBITDA
-1.74 -1.90 -1.73 -1.65 -3.45 -4.60 -3.17 -4.52 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.05 0.09 0.07 0.07 0.11 0.12 0.03 0.00 0.00 0.00 0.00
Debt to NOPAT
0.08 0.16 0.14 0.11 0.25 0.25 0.12 0.16 0.00 0.00 0.00
Net Debt to NOPAT
-2.76 -3.05 -3.07 -2.52 -6.72 -8.74 -5.31 -11.34 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.07 0.15 0.13 0.11 0.22 0.22 0.06 0.00 0.00 0.00 0.00
Altman Z-Score
17.64 16.40 22.98 12.83 16.62 23.42 15.71 10.52 13.75 9.50 8.66
Noncontrolling Interest Sharing Ratio
0.05% 0.05% 0.00% 0.02% 0.03% 0.04% 0.04% 0.01% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
7.78 8.22 8.82 7.35 9.88 10.01 7.49 7.23 8.91 6.98 6.08
Quick Ratio
5.92 6.23 6.80 5.29 7.41 7.71 5.67 5.06 6.50 5.37 4.36
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
211 82 160 144 115 175 253 145 171 -2.15 -109
Operating Cash Flow to CapEx
376.65% 235.55% 366.37% 246.87% 243.48% 328.70% 320.22% 255.35% 373.52% 354.41% 96.75%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.68 0.62 0.68 0.59 0.50 0.42 0.48 0.48 0.47 0.39 0.43
Accounts Receivable Turnover
6.14 6.57 7.17 5.93 5.32 4.78 5.55 6.04 5.98 5.01 5.69
Inventory Turnover
2.18 2.05 2.24 1.85 1.81 1.77 1.85 1.80 1.55 1.73 2.08
Fixed Asset Turnover
3.20 3.01 3.36 2.91 2.30 2.00 2.37 2.35 2.18 1.64 1.64
Accounts Payable Turnover
18.84 16.70 19.38 18.47 22.27 24.93 18.74 17.13 19.93 19.97 16.67
Days Sales Outstanding (DSO)
59.45 55.57 50.93 61.60 68.58 76.42 65.77 60.44 61.01 72.87 64.16
Days Inventory Outstanding (DIO)
167.06 178.00 163.04 196.80 202.08 205.68 197.13 202.54 235.73 210.97 175.43
Days Payable Outstanding (DPO)
19.37 21.86 18.83 19.76 16.39 14.64 19.48 21.31 18.32 18.28 21.90
Cash Conversion Cycle (CCC)
207.14 211.72 195.14 238.65 254.27 267.46 243.42 241.67 278.42 265.56 217.68
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
591 768 955 1,207 1,262 1,241 1,267 1,224 1,238 1,094 1,212
Invested Capital Turnover
1.57 1.48 1.64 1.35 1.07 0.96 1.17 1.15 1.05 0.84 0.87
Increase / (Decrease) in Invested Capital
31 177 187 252 55 -21 26 -43 14 -144 118
Enterprise Value (EV)
4,038 4,453 10,414 5,051 6,551 10,576 7,697 3,450 3,915 2,215 2,100
Market Capitalization
4,706 5,242 11,481 6,050 7,691 11,928 9,177 4,612 5,093 3,145 3,016
Book Value per Share
$23.86 $29.33 $37.72 $41.30 $45.26 $48.65 $51.52 $48.97 $51.48 $46.81 $50.52
Tangible Book Value per Share
$23.63 $28.41 $35.72 $37.78 $42.31 $46.70 $49.81 $47.48 $50.10 $43.98 $47.63
Total Capital
1,280 1,599 2,071 2,252 2,444 2,632 2,781 2,401 2,415 2,024 2,128
Total Debt
20 41 49 45 42 38 34 16 0.00 0.00 0.00
Total Long-Term Debt
18 38 45 42 38 34 16 0.00 0.00 0.00 0.00
Net Debt
-669 -790 -1,067 -999 -1,141 -1,353 -1,480 -1,162 -1,177 -930 -916
Capital Expenditures (CapEx)
70 126 111 159 133 87 122 83 79 70 78
Debt-free, Cash-free Net Working Capital (DFCFNWC)
274 315 443 519 526 546 538 550 522 296 350
Debt-free Net Working Capital (DFNWC)
963 1,146 1,559 1,563 1,708 1,937 2,052 1,728 1,700 1,226 1,189
Net Working Capital (NWC)
961 1,143 1,555 1,560 1,705 1,933 2,034 1,712 1,700 1,226 1,189
Net Nonoperating Expense (NNE)
0.30 -1.60 -0.48 -8.31 -11 -5.48 1.06 -8.37 -34 36 -22
Net Nonoperating Obligations (NNO)
-669 -790 -1,067 -999 -1,141 -1,353 -1,480 -1,162 -1,177 -930 -916
Total Depreciation and Amortization (D&A)
42 51 65 80 96 95 99 86 45 44 53
Debt-free, Cash-free Net Working Capital to Revenue
30.37% 31.33% 31.41% 35.52% 40.00% 45.49% 36.82% 38.48% 40.57% 30.27% 34.88%
Debt-free Net Working Capital to Revenue
106.83% 113.88% 110.63% 107.09% 129.96% 161.35% 140.49% 120.85% 132.03% 125.47% 118.49%
Net Working Capital to Revenue
106.61% 113.57% 110.38% 106.83% 129.68% 161.03% 139.25% 119.73% 132.03% 125.47% 118.49%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.60 $4.91 $6.50 $7.55 $3.40 $3.00 $5.21 $2.17 $4.64 ($4.09) $0.73
Adjusted Weighted Average Basic Shares Outstanding
52.68M 53.07M 53.50M 53.52M 53.06M 53.19M 53.41M 50.76M 47.15M 44.34M 42.34M
Adjusted Diluted Earnings per Share
$4.53 $4.85 $6.36 $7.38 $3.35 $2.97 $5.16 $2.16 $4.63 ($4.09) $0.73
Adjusted Weighted Average Diluted Shares Outstanding
53.43M 53.80M 54.70M 54.73M 53.84M 53.79M 53.93M 50.92M 47.32M 44.34M 42.65M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
52.89M 53.52M 54.06M 105.92M 53.06M 53.53M 52.94M 47.63M 46.10M 42.55M 42.19M
Normalized Net Operating Profit after Tax (NOPAT)
242 259 347 396 202 191 279 137 185 6.27 9.45
Normalized NOPAT Margin
26.89% 25.75% 24.64% 27.12% 15.35% 15.87% 19.09% 9.61% 14.41% 0.64% 0.94%
Pre Tax Income Margin
37.90% 36.43% 39.17% 36.61% 18.89% 17.13% 25.09% 12.83% 21.35% -16.57% 4.49%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 3.43% 11.56% 43.56% 22.60% 23.63% 48.54% 450.97% 102.11% -189.40% 170.86%

Quarterly Metrics And Ratios for IPG Photonics

This table displays calculated financial ratios and metrics derived from IPG Photonics' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 42,191,353.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 42,191,353.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.04
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-13.64% -10.39% -27.41% -24.22% -22.65% -21.60% -9.61% -2.69% 7.57% 17.13% 16.55%
EBITDA Growth
-42.73% 156.93% -67.82% -74.15% -460.70% -28.86% -48.51% -46.33% 108.55% -22.86% -40.68%
EBIT Growth
-40.16% 132.75% -74.36% -83.09% -550.87% -49.60% -83.68% -97.79% 103.30% -76.53% -286.16%
NOPAT Growth
-38.62% 145.66% -74.85% -82.37% -492.60% -82.49% -95.28% -99.14% 102.11% -15.79% -1,959.18%
Net Income Growth
-28.30% 144.60% -59.93% -67.66% -524.76% -81.14% -84.41% -67.23% 103.19% 69.80% -57.85%
EPS Growth
-21.09% 152.33% -58.73% -65.65% -559.48% -70.00% -82.69% -64.44% 103.38% 11.11% -55.56%
Operating Cash Flow Growth
13.33% 154.82% 46.45% -19.81% -23.17% -30.43% -75.37% -104.15% -46.55% -60.95% -140.63%
Free Cash Flow Firm Growth
581.13% 175.18% 3.34% -35.87% -114.14% 947.28% -30.73% -112.59% -374.40% -176.61% -263.65%
Invested Capital Growth
-8.20% 1.15% -6.54% -8.65% -12.41% -11.60% -5.58% 1.30% 9.95% 10.78% 8.71%
Revenue Q/Q Growth
-11.35% -0.83% -15.69% 2.24% -9.51% 0.51% -2.79% 10.07% 0.03% 9.44% -3.27%
EBITDA Q/Q Growth
-20.48% -42.31% -37.85% -23.52% -1,209.49% 111.38% -46.67% -20.28% 76.65% 2.72% -58.99%
EBIT Q/Q Growth
-22.25% -48.49% -32.51% -37.02% -2,173.05% 105.76% -78.29% -91.49% 3,000.37% -59.06% -272.25%
NOPAT Q/Q Growth
-17.91% -37.39% -51.57% -29.18% -1,927.99% 102.79% -86.94% -87.16% 4,409.06% 11.38% -388.30%
Net Income Q/Q Growth
-11.76% -24.67% -41.83% -16.37% -1,259.05% 103.35% -51.91% 75.76% 12.99% 77.81% -88.06%
EPS Q/Q Growth
-11.45% -22.41% -42.22% -13.46% -1,284.44% 105.07% -66.67% 77.78% 12.50% 66.67% -86.67%
Operating Cash Flow Q/Q Growth
28.97% 23.36% -48.52% -2.08% 23.57% 11.70% -81.78% -116.48% 1,693.23% -18.40% -118.96%
Free Cash Flow Firm Q/Q Growth
-17.79% -90.96% 588.90% 25.21% -118.12% 769.90% -54.44% -122.75% -583.07% -8.17% 2.67%
Invested Capital Q/Q Growth
-3.97% -1.00% -3.01% -0.93% -7.92% -0.09% 3.59% 6.30% -0.06% 0.67% 1.65%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
44.09% 38.20% 38.70% 37.33% 23.20% 38.55% 39.43% 37.32% 39.48% 36.10% 37.48%
EBITDA Margin
22.18% 12.91% 11.28% 8.44% -103.44% 11.71% 6.42% 4.65% 8.22% 7.71% 3.27%
Operating Margin
18.48% 9.63% 7.58% 4.67% -108.67% 5.95% 0.80% 0.04% 3.13% 1.21% -2.91%
EBIT Margin
18.66% 9.69% 7.71% 4.75% -108.78% 6.23% 1.39% 0.11% 3.34% 1.25% -2.22%
Profit (Net Income) Margin
18.25% 13.86% 9.56% 7.82% -100.19% 3.33% 1.65% 2.63% 2.98% 4.83% 0.60%
Tax Burden Percent
81.09% 98.28% 71.72% 80.58% 96.32% 35.50% 35.40% 79.86% 47.67% 125.71% 155.45%
Interest Burden Percent
120.57% 145.49% 172.98% 204.45% 95.62% 150.74% 334.75% 3,063.33% 187.00% 308.02% -17.26%
Effective Tax Rate
18.91% 1.72% 28.28% 19.42% 0.00% 64.50% 64.60% 20.14% 52.33% -25.71% -55.45%
Return on Invested Capital (ROIC)
15.17% 9.90% 5.22% 3.35% -67.56% 1.77% 0.23% 0.03% 1.25% 1.32% -3.99%
ROIC Less NNEP Spread (ROIC-NNEP)
14.33% 8.77% 4.27% 2.39% -62.33% 1.50% -0.07% -0.64% 0.86% 0.34% -5.49%
Return on Net Nonoperating Assets (RNNOA)
-6.79% -4.27% -2.00% -1.11% 29.83% -0.71% 0.03% 0.29% -0.39% -0.15% 2.38%
Return on Equity (ROE)
8.38% 5.62% 3.21% 2.25% -37.73% 1.06% 0.26% 0.31% 0.86% 1.17% -1.61%
Cash Return on Invested Capital (CROIC)
13.41% 13.86% 18.24% 16.79% 1.69% -0.18% -7.78% -15.18% -8.54% -9.45% -8.10%
Operating Return on Assets (OROA)
8.76% 4.59% 3.49% 2.03% -45.07% 2.44% 0.54% 0.04% 1.36% 0.53% -0.98%
Return on Assets (ROA)
8.56% 6.56% 4.33% 3.34% -41.52% 1.31% 0.64% 1.02% 1.21% 2.06% 0.26%
Return on Common Equity (ROCE)
8.38% 5.62% 3.21% 2.25% -37.73% 1.06% 0.26% 0.31% 0.86% 1.17% -1.61%
Return on Equity Simple (ROE_SIMPLE)
3.55% 0.00% 7.81% 6.24% -6.99% 0.00% -9.80% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
45 28 14 9.70 -177 4.95 0.65 0.08 3.74 4.17 -12
NOPAT Margin
14.99% 9.46% 5.44% 3.77% -76.07% 2.11% 0.28% 0.03% 1.49% 1.52% -4.53%
Net Nonoperating Expense Percent (NNEP)
0.84% 1.12% 0.95% 0.97% -5.23% 0.27% 0.30% 0.66% 0.39% 0.99% 1.50%
Return On Investment Capital (ROIC_SIMPLE)
- 1.17% - - - 0.24% 0.03% 0.00% 0.18% 0.20% -0.57%
Cost of Revenue to Revenue
55.91% 61.80% 61.30% 62.67% 76.80% 61.45% 60.57% 62.68% 60.52% 63.90% 62.52%
SG&A Expenses to Revenue
10.27% 11.71% 12.36% 12.27% 14.01% 12.33% 14.40% 13.91% 13.99% 14.70% 13.59%
R&D to Revenue
8.20% 9.27% 11.66% 10.67% 11.66% 10.98% 12.44% 11.94% 12.10% 10.48% 12.55%
Operating Expenses to Revenue
25.61% 29.02% 31.12% 32.66% 131.87% 32.60% 38.63% 37.28% 36.34% 34.89% 40.39%
Earnings before Interest and Taxes (EBIT)
56 29 19 12 -254 15 3.17 0.27 8.37 3.43 -5.90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
67 39 28 22 -241 27 15 12 21 21 8.68
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.02 2.11 1.82 1.71 1.55 1.55 1.30 1.39 1.59 1.42 2.29
Price to Tangible Book Value (P/TBV)
2.08 2.17 1.87 1.75 1.60 1.65 1.39 1.48 1.69 1.50 2.42
Price to Revenue (P/Rev)
3.64 3.96 3.57 3.46 3.16 3.22 2.82 3.09 3.47 3.00 4.64
Price to Earnings (P/E)
56.88 23.27 23.27 27.34 0.00 0.00 0.00 0.00 130.39 96.99 167.16
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.76% 4.30% 4.30% 3.66% 0.00% 0.00% 0.00% 0.00% 0.77% 1.03% 0.60%
Enterprise Value to Invested Capital (EV/IC)
2.94 3.16 2.59 2.34 2.07 2.02 1.55 1.68 2.03 1.73 3.21
Enterprise Value to Revenue (EV/Rev)
2.78 3.04 2.61 2.51 2.18 2.27 1.85 2.14 2.54 2.09 3.79
Enterprise Value to EBITDA (EV/EBITDA)
19.42 14.09 14.31 17.90 0.00 0.00 0.00 0.00 32.86 30.85 63.60
Enterprise Value to EBIT (EV/EBIT)
31.72 16.78 17.62 23.84 0.00 0.00 0.00 0.00 92.48 137.82 640.91
Enterprise Value to NOPAT (EV/NOPAT)
57.86 21.20 21.84 28.83 0.00 0.00 0.00 0.00 226.97 232.43 1,369.64
Enterprise Value to Operating Cash Flow (EV/OCF)
15.88 13.23 9.94 9.27 8.09 8.93 8.51 13.37 20.30 27.88 70.01
Enterprise Value to Free Cash Flow (EV/FCFF)
20.98 22.95 13.74 13.30 114.74 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.47 -0.49 -0.47 -0.46 -0.48 -0.47 -0.47 -0.45 -0.46 -0.44 -0.43
Leverage Ratio
1.14 1.13 1.13 1.12 1.12 1.12 1.12 1.12 1.12 1.14 1.13
Compound Leverage Factor
1.37 1.65 1.95 2.28 1.07 1.69 3.74 34.27 2.10 3.50 -0.20
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
12.76 13.50 12.67 12.32 10.54 9.82 8.92 8.95 9.84 8.65 12.02
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
8.74 8.91 9.52 9.02 8.09 6.98 7.33 6.79 6.72 6.08 5.80
Quick Ratio
6.20 6.50 6.89 6.51 6.09 5.37 5.60 5.07 4.86 4.36 4.07
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
157 14 98 122 -22 149 68 -15 -105 -114 -111
Operating Cash Flow to CapEx
0.00% 434.48% 1,956.85% 252.09% 289.42% 319.05% 54.58% -14.80% 170.65% 163.93% -35.25%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.47 0.47 0.45 0.43 0.41 0.39 0.39 0.39 0.41 0.43 0.44
Accounts Receivable Turnover
6.22 5.98 5.67 5.45 5.30 5.01 5.28 5.02 5.84 5.69 5.64
Inventory Turnover
1.61 1.55 1.49 1.50 1.70 1.73 1.73 1.75 1.83 2.08 2.14
Fixed Asset Turnover
2.13 2.18 2.02 1.85 1.78 1.64 1.60 1.56 1.59 1.64 1.68
Accounts Payable Turnover
18.91 19.93 20.72 21.03 18.70 19.97 19.27 18.25 14.81 16.67 14.04
Days Sales Outstanding (DSO)
58.64 61.01 64.38 66.97 68.88 72.87 69.12 72.77 62.48 64.16 64.72
Days Inventory Outstanding (DIO)
226.64 235.73 244.57 243.31 214.95 210.97 210.95 208.04 199.10 175.43 170.24
Days Payable Outstanding (DPO)
19.31 18.32 17.62 17.36 19.52 18.28 18.94 20.00 24.65 21.90 26.00
Cash Conversion Cycle (CCC)
265.97 278.42 291.33 292.92 264.30 265.56 261.13 260.80 236.94 217.68 208.96
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,250 1,238 1,201 1,189 1,095 1,094 1,134 1,205 1,204 1,212 1,232
Invested Capital Turnover
1.01 1.05 0.96 0.89 0.89 0.84 0.82 0.79 0.84 0.87 0.88
Increase / (Decrease) in Invested Capital
-112 14 -84 -113 -155 -144 -67 15 109 118 99
Enterprise Value (EV)
3,676 3,915 3,115 2,782 2,268 2,215 1,760 2,020 2,443 2,100 3,951
Market Capitalization
4,810 5,093 4,255 3,846 3,287 3,145 2,687 2,920 3,343 3,016 4,835
Book Value per Share
$50.33 $51.48 $50.93 $49.45 $47.81 $46.81 $48.43 $49.48 $49.85 $50.52 $50.08
Tangible Book Value per Share
$48.93 $50.10 $49.55 $48.10 $46.44 $43.98 $45.54 $46.51 $46.92 $47.63 $47.29
Total Capital
2,384 2,415 2,341 2,253 2,115 2,024 2,060 2,105 2,105 2,128 2,116
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-1,133 -1,177 -1,140 -1,064 -1,019 -930 -927 -900 -901 -916 -883
Capital Expenditures (CapEx)
-2.57 24 2.79 21 23 23 25 15 21 18 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
567 522 497 464 357 296 319 358 351 350 373
Debt-free Net Working Capital (DFNWC)
1,701 1,700 1,637 1,527 1,376 1,226 1,246 1,257 1,221 1,189 1,186
Net Working Capital (NWC)
1,701 1,700 1,637 1,527 1,376 1,226 1,246 1,257 1,221 1,189 1,186
Net Nonoperating Expense (NNE)
-9.82 -13 -10 -10 56 -2.86 -3.11 -6.52 -3.72 -9.10 -14
Net Nonoperating Obligations (NNO)
-1,133 -1,177 -1,140 -1,064 -1,019 -930 -927 -900 -901 -916 -883
Total Depreciation and Amortization (D&A)
11 9.60 9.00 9.50 12 13 11 11 12 18 15
Debt-free, Cash-free Net Working Capital to Revenue
42.91% 40.57% 41.72% 41.76% 34.26% 30.27% 33.53% 37.80% 36.40% 34.88% 35.82%
Debt-free Net Working Capital to Revenue
128.64% 132.03% 137.34% 137.62% 132.12% 125.47% 130.79% 132.90% 126.72% 118.49% 113.87%
Net Working Capital to Revenue
128.64% 132.03% 137.34% 137.62% 132.12% 125.47% 130.79% 132.90% 126.72% 118.49% 113.87%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.16 $0.90 $0.52 $0.45 ($5.33) $0.27 $0.09 $0.16 $0.18 $0.30 $0.04
Adjusted Weighted Average Basic Shares Outstanding
47.24M 47.15M 45.96M 44.92M 43.84M 44.34M 42.60M 42.48M 42.20M 42.34M 42.24M
Adjusted Diluted Earnings per Share
$1.16 $0.90 $0.52 $0.45 ($5.33) $0.27 $0.09 $0.16 $0.18 $0.30 $0.04
Adjusted Weighted Average Diluted Shares Outstanding
47.39M 47.32M 46.17M 45.01M 43.84M 44.34M 42.83M 42.58M 42.56M 42.65M 42.91M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
46.92M 46.10M 45.57M 44.23M 43.25M 42.55M 42.53M 42.22M 42.12M 42.19M 42.44M
Normalized Net Operating Profit after Tax (NOPAT)
45 28 14 9.70 -20 9.77 1.28 0.08 5.80 2.32 4.03
Normalized NOPAT Margin
14.92% 9.49% 5.44% 3.77% -8.75% 4.17% 0.56% 0.03% 2.31% 0.85% 1.52%
Pre Tax Income Margin
22.50% 14.10% 13.33% 9.71% -104.02% 9.39% 4.66% 3.30% 6.24% 3.85% 0.38%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
326.59% 102.11% 109.39% 229.24% -236.93% -189.40% -125.87% -75.20% 405.37% 170.86% 184.07%

Financials Breakdown Chart

Key Financial Trends

IPG Photonics (IPGP) has shown a mix of growth and expense pressures across its latest four quarters. The data below highlights the most important year-to-date trends from the last four years of quarterly statements.

  • Q4 2025 revenue rebound vs. prior year: Operating revenue was 274,471,000 USD in Q4 2025, up from 234,337,000 USD in Q4 2024 (+40.1 million, roughly +17%).
  • Q4 2025 net income up YoY: Net income attributable to common shareholders was 13,270,000 USD in Q4 2025 vs 7,815,000 USD in Q4 2024.
  • EPS improvement in Q4 2025: Basic and diluted earnings per share were 0.30 USD in Q4 2025, up from 0.27 USD (basic) in Q4 2024, indicating rising profitability per share.
  • Solid operating cash flow in 2025 quarters: Cash flow from continuing operating activities remained positive, with 35.3 million USD in Q3 2025 and 28.8 million USD in Q4 2025 (illustrating ongoing cash generation).
  • Strong balance sheet footprint: Total equity around 2.1 billion USD and total assets near 2.38 billion USD in recent quarters, indicating a substantial equity cushion versus liabilities.
  • Liquidity remains ample: Cash and cash equivalents typically sit in the mid-to-upper 300 million USD range (e.g., Q1–Q3 2025: about 346–363 million USD), supporting near-term liquidity needs.
  • Gross margin modestly declined: Q4 2025 gross margin was about 36.1% (gross profit 99,073,000 on 274,471,000 revenue), down from roughly 38–39% in late 2024, indicating some margin compression as costs rise.
  • Rising operating expenses: SG&A, marketing, and R&D expense increased in 2025, contributing to higher total operating expenses and narrowing operating income in some quarters.
  • Significant investing activity in some quarters: Several periods show large cash outlays for investments and related activity (e.g., substantial investments purchased in some quarters and sizable sales in others), which can temper free cash flow on a quarterly basis.
  • Investing cash outflows in some quarters: In several periods, net cash from investing activities was negative due to heavy purchases of investments and capital allocations (e.g., large investment purchases in 2025 and prior years). This reduced cash despite strong CFO in some quarters.
  • Financing cash outflows over multiple quarters: Net cash from financing activities was negative in multiple 2025 quarters (e.g., Q3 and Q4 2025) due to share repurchases and modest equity issuance, exerting pressure on cash held from financing activities.
  • Quarterly cash flow volatility: Net change in cash for some quarters has been negative (e.g., Q3 2025 and other periods), reflecting swings in investing/financing activity even as operating cash flow stays positive.
  • Margin and expense pressures may weigh on profitability: While profitability improved in Q4 2025 versus the prior year, the decline in gross margin and rising operating expenses suggest continued pressure on near-term earnings unless revenue growth accelerates or cost discipline improves.
05/25/26 03:41 PM ETAI Generated. May Contain Errors.

IPG Photonics Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IPG Photonics' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

IPG Photonics' net income appears to be on a downward trend, with a most recent value of $31.10 million in 2025, falling from $242.03 million in 2015. The previous period was -$181.53 million in 2024. See where experts think IPG Photonics is headed by visiting IPG Photonics' forecast page.

IPG Photonics' total operating income in 2025 was $13.10 million, based on the following breakdown:
  • Total Gross Profit: $381.46 million
  • Total Operating Expenses: $368.36 million

Over the last 10 years, IPG Photonics' total revenue changed from $901.27 million in 2015 to $1.00 billion in 2025, a change of 11.4%.

IPG Photonics' total liabilities were at $296.15 million at the end of 2025, a 11.8% increase from 2024, and a 53.6% increase since 2015.

In the past 10 years, IPG Photonics' cash and equivalents has ranged from $403.79 million in 2025 to $909.90 million in 2017, and is currently $403.79 million as of their latest financial filing in 2025.

Over the last 10 years, IPG Photonics' book value per share changed from 23.86 in 2015 to 50.52 in 2025, a change of 111.7%.



Financial statements for NASDAQ:IPGP last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners